Filter
5817
Filtered Results: 5817
Text search:
disease
therapy
Featured
Recommendations
545
New Publications
1468
Language
Document type
No document type
3536
Studies & Reports
834
Guidelines
794
Manuals
257
Strategic & Response Plan
129
Fact sheets
106
Training Material
70
Situation Updates
35
Infographics
21
Resource Platforms
14
Brochures
11
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
329
Global
206
Kenya
164
South Africa
147
Ethiopia
121
Uganda
118
Nigeria
110
Western and Central Europe
108
Nepal
107
Tanzania
95
Zambia
91
Sierra Leone
90
Malawi
90
Africa
80
Liberia
77
Rwanda
76
Latin America and the Carribbean
68
Bangladesh
62
Ghana
60
Ukraine
60
Eastern Europe
59
Myanmar / Burma
54
Russia
53
Indonesia
50
Namibia
50
Zimbabwe
47
Philippines
45
Asia
44
Lesotho
40
Congo, Democratic Republic of
35
Syria
35
Cambodia
33
Germany
31
South–East Asia Region
29
Mozambique
28
Senegal
27
Haiti
25
Brazil
25
South Sudan
24
Botswana
24
East and Southern Africa
23
West and Central Africa
23
Eswatini/ Swaziland
21
Middle East and North Africa
18
Cameroon
17
Burkina Faso
16
Guinea
15
Pakistan
13
Colombia
13
Yemen
13
Eastern Europe and Central Asia
13
Paraguay
13
Albania
13
Tajikistan
12
USA
11
Venezuela
11
Afghanistan
10
Sudan
9
Peru
9
Angola
9
Iraq
8
Benin
8
Madagascar
8
Western Pacific Region
8
Somalia
7
Thailand
7
Argentina
7
Bolivia
7
Armenia
7
Southern Africa
7
Moldova
7
Georgia
7
Vietnam
7
Central African Republic
6
North Macedonia
6
Ecuador
6
Jordan
5
Lebanon
5
China
5
Sri Lanka
5
Bhutan
5
Iran
5
Kyrgyzstan
5
North America
5
Spain
5
Mali
4
Guinea-Bissau
4
Saudi Arabia
4
Chile
4
Poland
4
Laos
4
United Kingdom
4
Turkey
3
Egypt
3
Chad
3
Papua New Guinea
3
Hungary
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Kazakhstan
3
Jamaica
3
Switzerland
2
Serbia
2
Libya
2
Other region
2
Fiji
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Gabon
2
France
2
Mauritius
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Togo
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Austria
1
Burundi
1
Greece
1
Mexico
1
Palestine
1
North Korea
1
Djibouti
1
Mongolia
1
Lithuania
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2190
Clinical Guidelines
603
Public Health
334
Women & Child Health
248
Key Resources
121
Capacity Building
85
Pharmacy & Technologies
60
Annual Report MEDBOX
2
Toolboxes
HIV
703
TB
507
Mental Health
495
COVID-19
342
AMR
242
NTDs
182
NCDs
178
Caregiver
149
Pharmacy
144
Disability
143
Ebola
111
Rapid Response
107
Conflict
88
Refugee
69
Planetary Health
54
Global Health Education
45
Natural Hazards
36
Cholera
33
Health Financing Toolbox
29
Polio
26
Specific Hazards
22
Zika
18
Social Ethics
12
South Sudan
1
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and...
Guidelines for Therapy and Management of Hypertension in Cardiovascular Disease in Indonesia
Chronic obstructive pulmonary disease (COPD) is a complex disease that requires differential diagnosis and proper classification to identify appropriate t.... Nonpharmacologic therapy and preventative measures should be utilized to prevent worsening of disease, symptoms, and complications. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines classify a patient’s COPD and provide recommendations for first-line treatment. The 2021 update included information regarding the use of e-cigarettes as nicotine replacement, triple therapy, and how the SARS-CoV-2 virus impacted patients with COPD. This article will focus on the diagnosis, classification, and treatment of COPD, as well as recently updated information regarding the use of e-cigarettes and the impact of COVID-19.
Clinical Practice Guidelines and Clinical Pathway for Therapy and Management of Heart Disease and Blood Vessels in Indonesia
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained healt...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment cri...
The document provides comprehensive guidance for people with COPD, covering treatment and medication management, oxygen therapy, mucus control, exercise, smoking cessation, nutrition, associated conditions, and strategies to prevent exacerbations. I...
The document provides practical guidance for individuals with COPD, covering topics such as medication management, oxygen therapy, mucus control, physical exercise, smoking cessation, nutrition, associated conditions, and how to prevent and manage e...
Severe and difficult asthma in a low- and middle-income country (LMIC) can relate to lack of availability of basic medications; potentially reversible factors such as poor adherence or comorbidities such as obesity inhibiting a good response to treatment; and (rarely) true severe, ...-resistant asthma. However, definitions of severity should encompass not merely doses of prescribed medication, but also underlying risk. The nature of asthmatic airway disease shows geographical variation, and LMIC asthma should not be assumed to be phenotypically the same as that in high-income countries (HICs). The first assessment step is to ensure another diagnosis is not being missed. Largely, political action is needed if children with asthma are to get access to basic medications. If a child is apparently not responding to low dose, simple medications, the next step is not to increase the dose but perform a detailed assessment of what factors (for example co-morbidities such as obesity, or social factors like poor adherence) are inhibiting a treatment response; in most cases, an underlying reason can be found. An assessment of risk of future severe asthma attacks, side-effects of medication and impaired lung development is also important. True severe, therapy-resistant asthma is rare and there are multiple underlying molecular pathologies. In HICs, steroid-resistant eosinophilia would be treated with omalizumab or mepolizumab, but the cost of these is prohibitive in LMICs, the biomarkers of successful therapy are likely only relevant to HICs. In LMICs, a raised blood eosinophil count may be due to parasites, so treating asthma based on the blood eosinophil count may not be appropriate in these settings.
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is...
Existing data on chronic obstructive pulmonary disease (COPD) prevalence are irregularly distributed around the world, and in many geographic regions data are scarce or even nonexistent. This fact hinders the implementation of adequate preventive an...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases inclu...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy a...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is comm...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased ris...
Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched. In the past few decades, deaths from NCDs in LMICs have spiked, whe...
The video titled "Personalizing Selection of Inhaled Delivery Systems in COPD" discusses the complexities healthcare professionals face when prescribing inhaled therapies for chronic obstructive pulmonary ... (COPD). It highlights the diverse range of available medications and delivery systems, noting that while medication categorization has been extensively studied, guidance on selecting appropriate inhaler devices remains limited and lacks consensus in COPD guidelines. The video proposes a novel strategy to address this issue, aiming to enhance the personalization of inhaled therapy for COPD patients.
Leprosy will be eliminated when we detect all patients and cure them by using multidrug therapy (MDT).
Elimination means bringing the disease burden down to a very low level. This will lead to a ...
